Get on Board: Inside the Board of Directors

If you would like to serve on a board, are already on a board, or work with a board, join us for Get on Board! The panelists are directors of both for-profit and nonprofit organization boards, and will address issues relating to service as directors, including the combinations of skills and experiences that boards are seeking, how to best position yourself for nonprofit or for-profit board candidacy, resources available to help you identify and take advantage of both paid and volunteer board opportunities, what it’s like to serve as a director on a board, and issues particular to women on boards. The discussion will be moderated by Ann Miller.

Panelists include:

• Susan Graf, Board Chair & Audit Committee Chair, Finch Therapeutics
• John Sundy, Chief Medical Officer and Head of R&D, Seismic Therapeutic

Date and Time:  
June 21, 2023
6:00 - 9:00 PM

Cost:   
Members: $0; Non-Members: $10

Download Flyer

Register Here

 

Thanks to our sponsor:

 

Cambridge Consultants, part of Capgemini Invent, develops breakthrough products and services, creates and licenses intellectual property, and provides business consultancy in technology-critical issues for clients worldwide. For more than 60 years, we’ve helped our clients turn business opportunities into commercial successes, whether they are launching first-to-market products, entering new markets or expanding existing markets through the introduction of new technologies. 

Speaker Bios

Dr. Ann Miller spent 30+ years in the biopharma industry where she leveraged her breadth of commercialization expertise, clinical training, and commitment to team and capability building to make strategic choices and drive growth. Currently, she is a Director at Inovio Pharmaceuticals; previously, she was a Director at Puma Biotechnology and Allena Pharmaceuticals. Dr. Miller worked at Sanofi S.A. from 2012 until her retirement in September 2018, serving as Vice President of Marketing and Vice President of Global Marketing, Oncology Division. From 2009 to 2011, Dr. Miller served as Senior Vice President at Eisai Co., Ltd., leading the Primary Care and Specialty Business unit and then Pharmaceutical Services. Dr. Miller previously served in management roles of increasing responsibility at Amgen Inc. and Merck & Co., Inc. Dr. Miller received an M.D. from the Duke University School of Medicine and a B.A. in Chemistry, summa cum laude, from Duke University.  Currently, she is a mentor at the Founder’s Residency program at The Roux Institute at Northeastern University located in Portland and the Termeer Foundation.